Equillium, Inc.
EQNasdaqCIK 1746466HealthcareFiscal year ends Dec 31
Reports and events: 155 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0517:06 ET | 8-K | 8.01 Other events | 0001193125-26-414364 |
| 2026-08-1316:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-349235 |
| 2026-08-1316:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-349182 |
| 2026-05-2916:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-248246 |
| 2026-05-1316:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-221625 |
| 2026-05-1316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-221595 |
| 2026-04-1509:00 ET | DEF 14A | Proxy statementPeriod 2026-05-28 | 0001193125-26-156092 |
| 2026-03-2516:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-124143 |
| 2026-03-2516:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-124107 |
| 2026-03-1308:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-105083 |
| 2025-11-1316:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-280202 |
| 2025-11-1316:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-280173 |
| 2025-10-2416:05 ET | 8-K/A | 4.01 Change of auditor | 0001193125-25-249953 |
| 2025-10-0616:05 ET | 8-K | 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-231860 |
| 2025-09-1916:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-209068 |
| 2025-09-0416:01 ET | 8-K | 8.01 Other events | 0000950170-25-113023 |
| 2025-08-1416:02 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-108834 |
| 2025-08-1108:35 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-177510 |
| 2025-08-0408:35 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-172207 |
| 2025-06-1316:05 ET | 8-K | 3.01 Delisting notice | 0000950170-25-086155 |
| 2025-05-2217:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-125153 |
| 2025-05-1416:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-071389 |
| 2025-04-2409:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-092435 |
| 2025-04-1007:00 ET | DEF 14A | Proxy statementPeriod 2025-05-21 | 0000950170-25-052669 |
| 2025-03-2707:10 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-045726 |
| 2025-03-2707:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-045723 |
| 2025-02-0608:01 ET | 8-K | 8.01 Other events | 0001193125-25-021348 |
| 2024-12-1316:04 ET | 8-K | 3.01 Delisting notice | 0001193125-24-278465 |
| 2024-12-1216:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-277043 |
| 2024-11-1316:10 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-126322 |
| 2024-11-1316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-126288 |
| 2024-10-3107:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-248138 |
| 2024-10-3118:49 ET | 8-K | 8.01 Other events | 0001193125-24-247760 |
| 2024-08-0816:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-093949 |
| 2024-08-0816:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093884 |
| 2024-07-2316:01 ET | 8-K | 3.01 Delisting notice | 0001193125-24-182856 |
| 2024-07-1814:08 ET | 8-K | 2.02 Results of operations | 0001193125-24-180952 |
| 2024-06-0408:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-153667 |
| 2024-05-2317:00 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-064016 |
| 2024-05-0916:11 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-056960 |
| 2024-05-0916:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056890 |
| 2024-04-1116:06 ET | DEF 14A | Proxy statementPeriod 2024-05-22 | 0001193125-24-093200 |
| 2024-04-0108:05 ET | 8-K | 8.01 Other events | 0001193125-24-082709 |
| 2024-03-2516:11 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-035919 |
| 2024-03-2516:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-076471 |
| 2024-03-0816:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-063618 |
| 2024-02-2317:12 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-044664 |
| 2024-02-2206:08 ET | 8-K | 8.01 Other events | 0001193125-24-041994 |
| 2023-12-2108:05 ET | 8-K | 8.01 Other events | 0001193125-23-300417 |
| 2023-11-0816:10 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-061108 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 17:10 ET. Listed shows no prices and gives no investment advice.